Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.
about
The protease inhibitor bikunin, a novel anti-metastatic agentEffect of NF-κB p65 antisense oligodeoxynucleotide on transdifferentiation of normal human lens epithelial cells induced by transforming growth factor-β2Inflammatory versus proliferative processes in epidermis. Tumor necrosis factor alpha induces K6b keratin synthesis through a transcriptional complex containing NFkappa B and C/EBPbeta.Effect of antisense oligodeoxynucleotide targeted against NF-κB/P65 on cell proliferation and tumorigenesis of gastric cancer.Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction.High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice.Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells.Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function.NF-kappa B-mediated regulation of urokinase gene expression by PMA and TNF-alpha in human A549 cells.Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells.
P2860
Q24305858-EAAF9ED9-E184-4DCE-9144-E5E7E9A1FEADQ35947489-A4212F69-4177-47AE-9C10-CA93E81DE845Q38310679-D73C0CE5-CC4A-4BCE-91D1-982C4B35B9F5Q39414144-09211C4D-0DC7-4AF9-BA6D-F6FF0894D2C4Q40637647-512BA426-A0CF-4C03-90EC-9D42446F5DA0Q40784517-D60AB843-A08C-420B-9438-43A49FE5F6D9Q40978991-BEAA6FAB-63B0-4EAE-8E3A-82C0C9619DCBQ40994004-A748C988-99C6-4E65-9DD4-DAC79224D60FQ41168579-E81354BE-3407-45F7-84FF-E143C14B3081Q43594124-C94EEC0B-1A3C-4EFD-9013-254D1BC77B2B
P2860
Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Inhibition of NF-kappa B-Rel A ...... ) but not its inhibitor PAI-1.
@ast
Inhibition of NF-kappa B-Rel A ...... ) but not its inhibitor PAI-1.
@en
Inhibition of NF-kappa B-Rel A ...... ase-type plasminogen activator
@nl
type
label
Inhibition of NF-kappa B-Rel A ...... ) but not its inhibitor PAI-1.
@ast
Inhibition of NF-kappa B-Rel A ...... ) but not its inhibitor PAI-1.
@en
Inhibition of NF-kappa B-Rel A ...... ase-type plasminogen activator
@nl
prefLabel
Inhibition of NF-kappa B-Rel A ...... ) but not its inhibitor PAI-1.
@ast
Inhibition of NF-kappa B-Rel A ...... ) but not its inhibitor PAI-1.
@en
Inhibition of NF-kappa B-Rel A ...... ase-type plasminogen activator
@nl
P2093
P2860
P356
P1476
Inhibition of NF-kappa B-Rel A ...... ) but not its inhibitor PAI-1.
@en
P2093
Guerrini L
Nishiguchi T
P2860
P304
P356
10.1093/NAR/23.19.3887
P407
P577
1995-10-01T00:00:00Z